These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25788864)

  • 1. Serum microRNA-205 as a novel biomarker for cervical cancer patients.
    Ma Q; Wan G; Wang S; Yang W; Zhang J; Yao X
    Cancer Cell Int; 2014; 14():81. PubMed ID: 25788864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
    Zhao S; Yao D; Chen J; Ding N
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Wang Q; Qin J; Chen A; Zhou J; Liu J; Cheng J; Qiu J; Zhang J
    Tumour Biol; 2015 May; 36(5):3703-8. PubMed ID: 25560490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
    Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
    J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
    Zhou GH; Yang WH; Sun B
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5696-5701. PubMed ID: 29272005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
    Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
    QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.